454 related articles for article (PubMed ID: 22751174)
1. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
4. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
5. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
7. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
8. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
Winkler EA; Nishida Y; Sagare AP; Rege SV; Bell RD; Perlmutter D; Sengillo JD; Hillman S; Kong P; Nelson AR; Sullivan JS; Zhao Z; Meiselman HJ; Wendy RB; Soto J; Abel ED; Makshanoff J; Zuniga E; De Vivo DC; Zlokovic BV
Nat Neurosci; 2015 Apr; 18(4):521-530. PubMed ID: 25730668
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
10. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
12. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
Fisher RA; Miners JS; Love S
Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.
Erickson MA; Banks WA
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1500-13. PubMed ID: 23921899
[TBL] [Abstract][Full Text] [Related]
17. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.
ElAli A; Thériault P; Préfontaine P; Rivest S
Acta Neuropathol Commun; 2013 Nov; 1():75. PubMed ID: 24252187
[TBL] [Abstract][Full Text] [Related]
18. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.
Cao Y; Xu H; Zhu Y; Shi MJ; Wei L; Zhang J; Cheng S; Shi Y; Tong H; Kang L; Lu L; Luo H; Yang X; Bai X; Wang R; Ma Y; Wang Y; Wang Z; Zhong K; Zhao BQ; Fan W
PLoS Biol; 2019 Jun; 17(6):e3000313. PubMed ID: 31185010
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
